Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeneFIX On-Demand Treatment in Chinese Hemophilia B Patients
NCT00866606Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2009
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor ix recombinant in hemophilia B (HB), sponsored by Pfizer. Started Feb 2009; status: completed.
02
Drugs
coagulation factor ix recombinant
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT00866606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866606.